Repaglinide RC C:
(S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]-amino]-2-oxoethyl] benzoic acid ; CAS : 107362-12-9 ; C30H34N2O4 ; MW: 486.6 ; |
Repaglinide Impurity A :
4-(Carboxymethyl)-2-ethoxybenzoic acid ; CAS : 220438-80-2 ; C11H12O5 ; MW: 224.21 ; |
Repaglinide Impurity B:
[3-Ethoxy-4-(ethoxycarbonyl)phenyl]acetic acid ; CAS : 99469-99-5 ; C13H16O5 ; MW: 252.26 ; |
Repaglinide Impurity C:
(1S)-3-Methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine oxalate ; CAS : 219921-94-5 (N-Acetyl-L-glutamate salt) ; C16H26N2 (base) ; MW: 246.39 (base) ; C18H28N2O4 (oxalate salt) ; MW: 336.43 ; |
Repaglinide Impurity D:
Ethyl 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl] butyl] amino]-2-oxoethyl]benzoate ; CAS : 147770-06-7 ; C29H40N2O4 ; MW: 480.64 ; |
Repaglinide Impurity E:
2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid ; CAS : 147852-26-4 ; C27H36N2O4 ; MW: 452.59 ; |